NCT05794061 · RECRUITING

Advances in Neuropsychological Diagnostics

This study is developing and refining neuropsychological tests used to diagnose cognitive impairment and dementia — tools like memory and thinking assessments given in clinics or remotely. Researchers are building and validating these instruments in both healthy Italian adults and patients with neurological or psychiatric conditions. There is no phase designation because this is not a drug or device trial — it is a diagnostic and psychometric research project.

Eligibility criteria

Inclusion Criteria:
* Clinical populations: clinical diagnosis of either neurological (e.g., vascular and degenerative aetiologies) or psychiatric disorders.
* Healthy controls: not applicable
Exclusion Criteria:
* Clinical populations:
  1. Clinical diagnosis not of interest;
  2. Severe general medical conditions;
  3. Uncorrected vision/hearing deficits.
* Healthy controls:
  1. Presence of brain disorders;
  2. Severe general medical conditions;
  3. Uncorrected vision/hearing deficits.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-09-17

View full record on ClinicalTrials.gov

All APOE4 clinical trials